Patent ID: 8623891
Filing Date: 2014-01-07
Classification: A61K,A61P

Abstract:
1. A method for treating a cognitive disorder, the method comprising administering to a patient in need of such treatment a therapeutically effective amount of at least one compound of the following structure: an enantiomer, a diastereomer, racemic mixture, or a pharmaceutically acceptable salt thereof; where: R R R the wavy lines represent bonds connected to carbons having R or S configuration; the dashed lines represent a bond or absence of a bond with the proviso that the ring containing the dashed lines is aromatic; m, n and q are independently 1; s is zero (0); X represents N; W, and Y independently represent CH; R R said carbocyclic ring jointly formed by R and wherein said cognitive disorder is associated with a neurodegenerative disease selected from the group consisting of Alzheimer's disease, corticobasal degeneration, Creutzfeldt-Jacob disease, frontotemporal lobar degeneration, Huntington disease, multiple sclerosis, normal pressure hydrocephalus, organic chronic brain syndrome, Parkinson's disease, Pick disease, progressive supranuclear palsy, and senile dementia (Alzheimer type).